Aller au contenu principal
Profil bibliographique

Joong-Yub Kim

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

8Publications signalées
61Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Tuberculosis Research and EpidemiologyMycobacterium research and diagnosisDiagnosis and treatment of tuberculosisGut microbiota and healthAntimicrobial Resistance in Staphylococcus

Les publications récentes

Accès ouvert 2026 article OpenAlex

Gut–lung axis and microbiome alterations in mycobacterial infections: from pathogenesis to therapeutic potential

Kimin Kang, Joong-Yub Kim, Jae-Joon Yim, Donghyun Kim

Mycobacterial lung diseases, including tuberculosis (TB) and nontuberculous mycobacterial pulmonary disease (NTM-PD), are increasingly recognized as disorders influenced not only by host immunity but also by microbiota. Emerging evidence identifies the gut-lung axis (GLA) as a key bidirectional communication network linking intestinal …

kr, Éthiopie, us, pr (code pays fourni par la source)

3 citations Gut Microbes
Accès ouvert 2025 review OpenAlex

Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: an individual patient data meta-analysis

Nakwon Kwak, Joong-Yub Kim, Catherine Berry, Maria Beumont et autres

Background The optimal dosing strategy of linezolid for treating multidrug-resistant and rifampicin-resistant tuberculosis remains unclear. We conducted an individual patient data meta-analysis to determine the optimal linezolid dosing strategy. Methods We searched for randomised controlled trials and prospective cohort studies on short-course …

kr, us, gb, Afrique du Sud, bd, be, vn, nl (code pays fourni par la source)

9 citations European Respiratory Journal
Accès ouvert 2024 article OpenAlex

Diagnosis and Treatment of Latent Tuberculosis Infection in Adults in South Korea

Kyung‐Wook Jo, Young-Soon Yoon, Hyung Woo Kim, Joong-Yub Kim et autres

Latent tuberculosis infection (LTBI) is characterized by immune responses to Mycobacterium tuberculosis antigens without clinical symptoms or evidence of active tuberculosis. Effective LTBI management is crucial for tuberculosis elimination, requiring accurate diagnosis and treatment. In South Korea, LTBI guidelines have been updated …

kr (code pays fourni par la source)

7 citations Tuberculosis & respiratory diseases
Accès ouvert 2024 article OpenAlex

Artificial intelligence-based radiographic extent analysis to predict tuberculosis treatment outcomes: a multicenter cohort study

Hyung‐Jun Kim, Nakwon Kwak, Soon Ho Yoon, Nanhee Park et autres

Predicting outcomes in pulmonary tuberculosis is challenging despite effective treatments. This study aimed to identify factors influencing treatment success and culture conversion, focusing on artificial intelligence (AI)-based chest X-ray analysis and Xpert MTB/RIF assay cycle threshold (Ct) values. In this retrospective study …

kr, pr (code pays fourni par la source)

10 citations Scientific Reports
Accès ouvert 2024 article OpenAlex

Change of erythrocyte sedimentation rate as prognostic biomarker for Mycobacterium avium complex pulmonary disease through anti-mycobacterial treatment

Hyeontaek Hwang, Joong-Yub Kim, Jae‐Joon Yim, Nakwon Kwak

BACKGROUND: It remains unclear whether erythrocyte sedimentation rate (ESR) accurately predicts prognosis during treatment and how ESR changes. OBJECTIVES: complex pulmonary disease (MAC-PD) while on anti-mycobacterial treatment and its changes according to the treatment responses. DESIGN: This study is a retrospective cohort …

kr (code pays fourni par la source)

0 citations Therapeutic Advances in Respiratory Disease
Accès ouvert 2021 article OpenAlex

Outcomes of adjunctive surgery for nontuberculous mycobacterial pulmonary disease

Joong-Yub Kim, Samina Park, In Kyu Park, Chang Hyun Kang et autres

BACKGROUND: Owing to the unsatisfactory results of antibiotic treatment alone, surgical resection is currently considered as adjunctive therapy in patients with nontuberculous mycobacterial pulmonary disease (NTM-PD). However, reports regarding the outcomes of surgery vary considerably by institution. Here, we investigated the surgical …

kr, pr (code pays fourni par la source)

15 citations BMC Pulmonary Medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.